Shareholder Buyout
Blarter, Have you got any friends in the pharma industry that would take a position in a shareholder buyout.
I have calculated that 23.5 cents is a 24% premium to management's valuation of a week ago. For the paltry sum of 38 mil we can take over the company and inject some life into the otherwise comatose Bioniche.
The NR itself, detailing the pipeline, would probably double the share price after a phone call or two.
How could they not recommend a premium of this magnitude to shareholders?